Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Argus Health
Baxter
Deloitte
Cipla
Fish and Richardson
Merck
Accenture
Medtronic

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019185

« Back to Dashboard

NDA 019185 describes OXYTOCIN 5 USP UNITS IN DEXTROSE 5%, which is a drug marketed by Abbott and is included in one NDA. Additional details are available on the OXYTOCIN 5 USP UNITS IN DEXTROSE 5% profile page.

The generic ingredient in OXYTOCIN 5 USP UNITS IN DEXTROSE 5% is oxytocin. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the oxytocin profile page.
Summary for 019185
Tradename:OXYTOCIN 5 USP UNITS IN DEXTROSE 5%
Applicant:Abbott
Ingredient:oxytocin
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019185

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength1USP UNITS/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 29, 1985TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2USP UNITS/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 29, 1985TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength2USP UNITS/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Mar 29, 1985TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Federal Trade Commission
Mallinckrodt
Moodys
QuintilesIMS
Merck
Cerilliant
McKinsey
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.